6-hydroxydopamine increases the level of TNFα and bax mRNA in the striatum and induces apoptosis of doparninergic neurons in hemiparkinsonian rats

被引:49
作者
Mladenovic, A
Perovic, M
Raicevic, N
Kanazir, S
Rakic, L
Ruzdijic, S
机构
[1] Inst Biol Res, Dept Neurobiol & Immunol, Mol Neurobiol Lab, YU-11060 Belgrade 11060, Serbia Monteneg, Serbia
[2] Serbian Acad Arts & Sci, Belgrade, Serbia Monteneg, Serbia
关键词
6-OHDA; DA-ergic neurons; apoptosis; TNF alpha; TNF alpha R1; bax;
D O I
10.1016/j.brainres.2003.10.035
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study was focused on the apoptosis (programmed cell death) induction involved in the loss of dopaminmergic (DA-ergic) neurons in 6-hydroxydopamine (6-OHDA) hemiparkinsonian rats. The apoptosis in the striatum and substantia nigra pars compacta (SNpc), was examined 6, 24 h and 7 days after the 6-OHDA lesions employing the TUNEL method. The changes in mRNA levels of pro-apoptotic protein tumor necrosis factor alpha (TNFalpha) and its "death receptor" TNFalphaRI and then bax mRNA, as an important regulator of apoptotic neurodegeneration were followed by RT-PCR procedure. In situ analysis revealed an increased number of TUNEL-positive neurons in 6-OHDA-treated animals in all examined time points. The highest number of apoptotic neurons was detected 24 h after the lesion, both in the ipsilateral striatum (3.41 +/- 0.18) and SNpc (5.8 +/- 0.79). A significant increase in the level of TNFalpha mRNA was observed in 6-OHDA-lesioned striatum, with maximal value after 24 h (46%) comparing to the control. In contrast, 6-OHDA did not significantly change the level of TNFalphaRI mRNA in any time point. Six and 24 h post-operatively, we observed a significant increase of bax mRNA expression (40% and 45%, respectively) in the ipsilateral striatum of treated animals in comparison with the right striatum of the controls. However, the highest level of the bax mRNA expression was reached 7 days after the surgery (94%) in the ipsilateral striatum of 6-OHDA-treated animals. These results suggest that striatal injection of 6-OHDA can induce early changes that would be an important regulator of apoptotic neurodegeneration of dopamine-producing neurons, during the first post-operative week. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:237 / 245
页数:9
相关论文
共 45 条
[1]   Does neuronal loss in Parkinson's disease involve programmed cell death? [J].
Andersen, JK .
BIOESSAYS, 2001, 23 (07) :640-646
[2]   IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease [J].
Bessler, H ;
Djaldetti, R ;
Salman, H ;
Bergman, M ;
Djaldetti, M .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :141-145
[3]   Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J].
Blum, D ;
Torch, S ;
Lambeng, N ;
Nissou, MF ;
Benabid, AL ;
Sadoul, R ;
Verna, JM .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) :135-172
[4]   p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells [J].
Blum, D ;
Wu, Y ;
Nissou, MF ;
Arnaud, S ;
Benabid, AL ;
Verna, JM .
BRAIN RESEARCH, 1997, 751 (01) :139-142
[5]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[6]   Pathophysiology of Parkinson's disease [J].
Bonnet, AM ;
Houeto, JL .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :117-121
[7]   Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease [J].
Eberhardt, O ;
Schulz, JB .
TOXICOLOGY LETTERS, 2003, 139 (2-3) :135-151
[8]   Oxidative stress and apoptosis in neurodegeneration [J].
Gorman, AM ;
McGowan, A ;
ONeill, C ;
Cotter, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 139 :45-52
[9]   The many faces of tumor necrosis factor in stroke [J].
Hallenbeck, JM .
NATURE MEDICINE, 2002, 8 (12) :1363-1368
[10]   Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice [J].
Hassouna, I ;
Wickert, H ;
Zimmermann, M ;
Gillardon, F .
NEUROSCIENCE LETTERS, 1996, 204 (1-2) :85-88